期刊文献+

Musashi-2在恶性血液病发病中作用的研究进展

Research Progress on the Role of Musashi-2 in the Pathogenesis of Malignant Hematologic Diseases——Review
下载PDF
导出
摘要 以往研究发现,Musashi-2(Msi-2)主要通过抑制或激活作用发挥对翻译的必要调节从而调控干细胞群的基因表达,并以此调控干细胞的功能。目前的研究表明,Msi-2可通过不同作用机制参与多种恶性血液病的调控,在多种恶性血液病中异常表达,参与了多种恶性血液病的发生、发展过程。对其在恶性血液病中作用的深入研究,将进一步阐明恶性血液病的发病机制,为恶性血液病的诊治及预后提供新的依据。 Previous studies have found that Musashi-2 (Msi-2) plays an essential role in regulating the gene expression of stem cell populations by inhibiting or activating the translation, and thus regulates stem cell function. Current research shows that Msi-2 involved in the regulation of a variety of malignant hematological diseases through different mechanisms; moreover abnormally expressed in a variety of malignant hematological diseases and involved in the occurrence, development of a variety of malignant hematological diseases. Further study on the role of malignant hematologic diseases will further clarify the pathogenesis of malignant hematologic diseases, and provide a new basis for the diagnosis and treatment of malignant hematological diseases. In this review, the structure and function of Msi-2 and its relationship with malignant hematologic diseases and its latest research progress are summarized.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2017年第2期633-636,共4页 Journal of Experimental Hematology
基金 国家自然科学基金(81060047 81160073) 江西省自然科学基金(20122BAB205024) 江西省卫生厅重大项目基金(20114011)
关键词 Msi-2 RNA结合蛋白 干细胞 白血病 Msi-2 RNA binding protein stem cell leukemia
  • 相关文献

参考文献5

二级参考文献65

  • 1Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 2Dhner H,Estey EH,Amadori S,et al.Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European Leukemia Net.Blood,2010;115(3):453-474.
  • 3Hope KJ,Cellot S,Ting SB,et al.An RNAi screen identifies Msi2and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity.Cell Stem Cell,2010;7(1):101-113.
  • 4Ito T,Kwon HY,Zimdahl B,et al.Regulation ofmyeloid leukaemia by the cell-fate determinant Musashi.Nature,2010,466(7307):765-768.
  • 5Kharas MG,Lengner CJ,Al-Shahrour F,et al.Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.Nat Med,2010;16(8):903-908.
  • 6Danovi SA.Leukaemia:comfortably MSI2-NUMB.Nat Rev Cancer,2010;10(9):602-603.
  • 7De Weer A,Speleman F,Cauwelier B,et al.Groupe Fran?ais de Cytogénétique Hématologique(GFCH).EVI1 overexpression int(3;17 )positive myeloid malignancies results from juxtaposition of EVI1to the MSI2 locus at 17q22.Haematologica,2008;93(12):1903-1907.
  • 8Barbouti A,Hglund M,Johansson B,et al.Anovel gene,MSI2,encoding a putative RNA-binding protein is recurrently rearranged at disease progressionof chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).Cancer Res,2003;63(6):1202-1206.
  • 9Griner LN,Reuther GW.Aggressive myeloid leukemia formation is directed by the Musashi 2/Numb pathway.Cancer Biol Ther,2010;10(10):979-982.
  • 10Kayahara T, Sawada M, Takaishi S, et al. Candidate markers for stem and early progenitor ceils, Musashi-1 and HeM, are expressed in crypt base columnar cells of mouse small intestine [J]. Febs Lett, 2003,535:131-135.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部